Antimalarial Drugs Inhibiting Hemozoin (Beta-hematin) Formation: a Mechanistic Update.
From: Division of Drug Target Discovery and Development, Central Drug Research Institute, Chatter Manzil Palace, Mahatma Gandhi Marg, Lucknow-226001, Uttar Pradesh, India.
Life sciences
- Publish Date: Feb 2007
- ISSN: 0024-3205
- Volume: 80
- Issue: 9
- Pages: 813-28
- Medium: Print
- Language: English
- Citation (JAMA): Kumar Sanjay, Guha Mithu, Choubey Vinay, et al. Antimalarial Drugs Inhibiting Hemozoin (Beta-hematin) Formation: a Mechanistic Update.. Life Sci. Feb 2007;80:813-28
Abstract
Digestion of hemoglobin in the food vacuole of the malaria parasite produces very high quantities of redox active toxic free heme. Hemozoin (beta-hematin) formation is a unique process adopted by Plasmodium sp. to detoxify free heme. Hemozoin formation is a validated target for most of the well-known existing antimalarial drugs and considered to be a suitable target to develop new antimalarials. Here we discuss the possible mechanisms of free heme detoxification in the malaria parasite and the mechanistic details of compounds, which offer antimalarial activity by inhibiting hemozoin formation. The chemical nature of new antimalarial compounds showing antimalarial activity through the inhibition of hemozoin formation has also been incorporated, which may help to design future antimalarials with therapeutic potential against multi-drug resistant malaria.
Mesh Headings (Keywords): Animals, Antimalarials, Hemeproteins, Humans, Malaria, Falciparum, Molecular Structure, Plasmodium falciparum, Structure-Activity Relationship
Check for Full Text / PubMed Unique Identifier (PMID): 17157328
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.